Evidence map›Paper›PMID 36335158›Full record

ArticleScientific reports2022

Correlation of T1- to T2-weighted signal intensity ratio with T1- and T2-relaxation time and IDH mutation status in glioma.

Takahiro Sanada, Shota Yamamoto, Mio Sakai, Toru Umehara, Hirotaka Sato, Masato Saito, Nobuyuki Mitsui, Satoru Hiroshima, Ryogo Anei, Yonehiro Kanemura and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Takahiro SanadaDepartment of Neurosurgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido, 078-8510, Japan.
Shota YamamotoDepartment of Neurosurgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido, 078-8510, Japan.
Mio SakaiDepartment of Diagnostic and Interventional Radiology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Toru UmeharaDepartment of Neurosurgery, Osaka University Graduate School of Medicine, Suita, 565-0871, Japan.
Hirotaka SatoDepartment of Neurosurgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido, 078-8510, Japan.
Masato SaitoDepartment of Neurosurgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido, 078-8510, Japan.
Nobuyuki MitsuiDepartment of Neurosurgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido, 078-8510, Japan.
Satoru HiroshimaDepartment of Neurosurgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido, 078-8510, Japan.
Ryogo AneiDepartment of Neurosurgery, Moriyama Hospital, Asahikawa, 078-8392, Japan.
Yonehiro KanemuraDepartment of Biomedical Research and Innovation, Institute for Clinical Research, National Hospital Organization Osaka National Hospital, Osaka, 540-0006, Japan.
Mishie TaninoDepartment of Diagnostic Pathology, Asahikawa Medical University Hospital, Asahikawa, 078-8510, Japan.
Katsuyuki NakanishiDepartment of Diagnostic and Interventional Radiology, Osaka International Cancer Institute, Osaka, 541-8567, Japan.
Haruhiko KishimaDepartment of Neurosurgery, Osaka University Graduate School of Medicine, Suita, 565-0871, Japan.
Manabu KinoshitaDepartment of Neurosurgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido, 078-8510, Japan. mail@manabukinoshita.com.
Asahikawa Medical University · JPOsaka Medical Center for Cancer and Cardiovascular Diseases · JPOsaka University · JPAsahikawa City Hospital · JPJapanese Red Cross Hokkaido College of Nursing · JPOsaka National Hospital · JP

Funding

Japan Agency for Medical Research and Development 19188187Japan Society for the Promotion of Science 19K09526
6 · The paper itself

Abstract

The current study aimed to test whether the ratio of T1-weighted to T2-weighted signal intensity (T1W/T2W ratio: rT1/T2) derived from conventional MRI could act as a surrogate relaxation time predictive of IDH mutation status in histologically lower-grade gliomas. Strong exponential correlations were found between rT1/T2 and each of T1- and T2-relaxation times in eight subjects (rT1/T2 = 1.63exp

Indexed as

Brain NeoplasmsGliomaHumansIsocitrate DehydrogenaseMagnetic Resonance ImagingMutationRetrospective StudiesIsocitrate Dehydrogenase

Identifiers

PMID36335158
PMCPMC9637175
OpenAlexW4308496367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.